Functional Shots Surge, Graza Explores Sale, Surgery Gets Scrutinized
September 29, 2026: Your daily rundown of health and wellness news, in under 5 minutes.
Today's top stories:
Functional shots emerge as the next supplement ritual, with the category projected to grow from $6.6B to $19B by 2033 as investors back brands like Sol-ti and Suja
The Economist questions the evidence behind common surgeries, finding roughly two-thirds of patient improvement in trials came from natural healing or placebo effects
Olive oil brand Graza explores a sale valued between $450M and $600M as larger food companies acquire brands reinventing familiar categories
More from Fitt…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.